跳至主要内容
临床试验/NCT04920851
NCT04920851Unknown不适用

Comparison of Cytokine Hemadsorption as an Immunomodulator Therapy in Covid 19 Patients With and Without Bacterial Sepsis

Derince Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2021年6月10日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
23
试验地点
1
主要终点
interleukin 6

研究概览

简要总结

In this retrospective study, we aimed to compare the laboratory and clinical results of cytokine hemadsorption as an immunomodulation therapy in COVID-19 ICU patients with or without sepsis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COVID-19 patients were the available data of laboratory diagnosis of COVID-19 (a positive throat swab nucleic acid test or positive serum COVID-19 specific antibody test),
  • patients with COVID-19 induced sepsis was detection of bacterial agent in blood or tracheal culture

排除标准

  • below 18 aged
  • those who did not undergo hemoperfusion

结局指标

主要结局

interleukin 6

时间窗: 1 month

level of interleukin 6

次要结局

未报告次要终点

研究者

发起方
Derince Training and Research Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

İLKE KÜPELİ

ASSOC. PROF

Biruni University

研究点 (1)

Loading locations...

相似试验